ImmunoPrecise Antibodies ...

0.59
-0.05 (-8.46%)
At close: Jan 23, 2025, 3:59 PM
0.56
-5.53%
After-hours Jan 23, 2025, 07:59 PM EST

ImmunoPrecise Antibodies Ltd. Revenue Breakdown

Quarter Apr 30, 2024
Product Sales Revenue 2.04M
Product Sales Revenue Growth n/a
Project Revenue Revenue 22.23M
Project Revenue Revenue Growth n/a

Revenue by Geography

Quarter Apr 30, 2024Apr 30, 2023Apr 30, 2022
Australia Revenue 482.00K 630.00K 1.54M
Australia Revenue Growth -23.49% -59.09% n/a
All Other Countries Revenue 224.00K 602.00K 1.01M
All Other Countries Revenue Growth -62.79% -40.22% n/a
Canada Revenue 389.00K 618.00K 572.00K
Canada Revenue Growth -37.06% +8.04% n/a
Europe Revenue 10.87M 9.45M 9.43M
Europe Revenue Growth +14.99% +0.22% n/a
United States Revenue 12.56M 9.37M 6.82M
United States Revenue Growth +34.07% +37.40% n/a

Operating Expense Breakdown

Quarter Oct 31, 2024Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Aug 9, 2023Apr 30, 2023Jan 31, 2023Dec 13, 2022Jul 31, 2022Apr 30, 2022Jan 31, 2022Oct 31, 2021Jul 31, 2021Apr 30, 2021Jan 31, 2021Oct 31, 2020Jul 31, 2020Apr 30, 2020Jan 31, 2020Oct 31, 2019Jul 31, 2019Apr 30, 2019Jan 31, 2019Oct 31, 2018Jul 31, 2018Apr 30, 2018Jan 31, 2018Oct 31, 2017Jul 31, 2017Apr 30, 2017Jan 31, 2017Oct 31, 2016Jul 31, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 4.51M 4.88M 5.03M 4.83M 4.23M 5.24M 7.60M 5.48M 5.09M 5.24M 5.87M 4.17M 3.63M 4.04M 4.53M 3.88M 2.91M 2.02M 2.87M 1.14M 2.23M 2.09M 1.92M 2.16M 2.26M 2.12M 2.23M 1.92M 1.23M 1.16M 1.23M 4.78M 241.22K 370.34K 4.11K 15.78K 2.40K 4.67K 8.18K
Selling, General, and Administrative Revenue Growth -7.60% -2.92% +4.16% +14.14% -19.28% -31.04% +38.66% +7.64% -2.84% -10.75% +40.90% +14.80% -10.28% -10.71% +16.79% +33.18% +44.34% -29.75% +152.48% -49.03% +7.00% +8.59% -11.09% -4.60% +6.68% -4.86% +16.24% +56.63% +5.65% -5.96% -74.17% +1879.70% -34.86% +8919.43% -73.98% +556.72% -48.51% -42.96% n/a
Research and Development Revenue 1.16M 1.64M 927.00K 1.00M 1.04M 5.78M 502.00K 1.03M 4.56M 5.78M 906.00K 1.82M 2.85M 1.12M 615.47K n/a 1.05M 309.21K -221.01K 54.19K 445.84K 167.26K 188.65K 60.05K 19.27K 31.79K 385.50K 64.68K 118.93K 106.32K 393.92K 72.89K n/a 59.22K 417.70K 59.55K 61.68K 49.81K n/a
Research and Development Revenue Growth -29.66% +77.13% -7.39% -3.47% -82.05% +1051.00% -51.36% -77.37% -21.08% +537.75% -50.22% -36.10% +154.51% +81.81% n/a -100.00% +239.35% -239.91% -507.85% -87.85% +166.56% -11.34% +214.16% +211.68% -39.39% -91.75% +495.99% -45.61% +11.86% -73.01% +440.41% n/a -100.00% -85.82% +601.39% -3.45% +23.84% n/a n/a
Sales and Marketing Revenue 1.24M 718.00K 909.00K 649.00K 921.00K 311.00K 934.00K 836.00K 817.00K 311.00K 151.00K 228.00K 198.00K 163.00K 186.19K 215.90K 255.60K 33.31K 151.46K 48.12K 60.95K 117.20K 139.32K 357.29K 268.88K 53.77K 19.20K 36.38K 46.10K 33.00K 92.87K 17.43K 4.89K 4.00K 4.30K 7.12K 5.50K 3.91K n/a
Sales and Marketing Revenue Growth +72.28% -21.01% +40.06% -29.53% +196.14% -66.70% +11.72% +2.33% +162.70% +105.96% -33.77% +15.15% +21.47% -12.46% -13.76% -15.53% +667.43% -78.01% +214.78% -21.05% -47.99% -15.88% -61.01% +32.88% +400.06% +180.11% -47.24% -21.08% +39.70% -64.47% +432.92% +256.31% +22.21% -6.97% -39.54% +29.29% +40.74% n/a n/a